Research Progress of Targeted Drug Therapy and Tumor Microenvironment Therapy for Non-Small Cell Lung Cancer

Read full text
Authors: Youlin Zheng
Cited by: 0

Abstract

In the past few years, along with the advancement of tumor immunology, immunotherapeutic approaches have offered more potent therapeutic choices for individuals diagnosed with cancer. Based on traditional chemotherapy and radiotherapy, immunotherapy has offered patients more effective strategies and better prognosis. Among them, immune-targeted drug therapy and tumor microenvironment therapy have achieved remarkable results in the management of non-small cell lung cancer (NSCLC). This study will elaborate on the mechanisms, research status quo and developments of targeted drug therapy and tumor microenvironment therapy in managing NSCLC.

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies

Publication details

Journal / source
International Journal of Biology and Life Sciences
Volume
13
Issue
1
Pages
6–9
Publication date
27 January 2026